Grifols Therapeutics LLC

Quick facts

Marketed products

• Diphtheria-Tetanus Toxoids Adsorbed
• GAMUNEX-C · Other
• IGSC 20%
• Immune Globulin (Human) · Immunology
  Immune Globulin (Human) provides passive immunization by supplying pooled human antibodies to enhance immune function and neutralize pathogens.
• Prolastin-C · Pulmonology / Respiratory
  Prolastin-C is a purified human alpha-1 protease inhibitor (AAT) that replaces deficient or dysfunctional alpha-1 antitrypsin to protect lung tissue from enzymatic degradation.
• Xembify · Other

Phase 3 pipeline

• Albutein 20%
• Alpha-1 MP
• IGIV-C 10% · Immunology
  IGIV-C 10% is an intravenous immunoglobulin (IVIG) preparation that provides passive immunity by supplying pooled human antibodies to modulate immune responses.
• IVIG-PEG · Immunology
  IVIG-PEG is a polyethylene glycol-conjugated intravenous immunoglobulin that provides passive immune protection by delivering pooled human antibodies with extended half-life.

Phase 2 pipeline

• Liquid Alpha₁-PI
• Plasminogen Activator

Phase 1 pipeline

• Alpha-1 15%
• Human Plasma-Derived Fibrinogen Concentrate
• RIG-C

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Grifols Therapeutics LLC portfolio CI brief
• Grifols Therapeutics LLC pipeline updates RSS

Frequently asked questions about Grifols Therapeutics LLC

Related

• Diphtheria-Tetanus Toxoids Adsorbed
• GAMUNEX-C · Other
• IGSC 20%
• Immune Globulin (Human) · Immunology
• Prolastin-C · Pulmonology / Respiratory
• Sector hub: All tracked pharma companies